How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

被引：5
|
作者：
Christoph Koenen
机构：
[1] Novo Nordisk A/S,
[2] Krogshøjvej 55,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷 / 10期
关键词：
D O I：
10.1038/ncpendmet0972
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E1 / E1
相关论文
共 50 条
  • [1] How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Jennifer B Marks
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 490 - 491
  • [2] Erratum: How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Jennifer B Marks
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 702 - 702
  • [3] How do detemir and glargine compare when added to oral agents in insulin-naive patients with type 2 diabetes mellitus?
    Marks, Jennifer B.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (09): : 490 - 491
  • [4] How do detemir and glargine compare when added to oral agents in insulin-naive patients with type 2 diabetes mellitus? (vol 4, pg 490, 2008)
    Marks, Jennifer B.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (12): : 702 - 702
  • [5] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    DIABETOLOGIA, 2011, 54 : S420 - S421
  • [6] All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK
    Lise Lotte Nystrup Husemoen
    Lina S. Mørch
    Per K. Christensen
    Niels V. Hartvig
    Michael D. Feher
    Diabetes Therapy, 2021, 12 : 1299 - 1311
  • [7] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [8] A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
    Pan C.
    Gross J.L.
    Yang W.
    Lv X.
    Sun L.
    Hansen C.T.
    Xu H.
    Wagner R.
    Drugs in R&D, 2016, 16 (2) : 239 - 249
  • [9] Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
    Natalia Duque
    Esther Artime
    Irene Romera
    Jeremie Lebrec
    Silvia Díaz
    Miriam Rubio
    Antoni Sicras-Mainar
    Enrique Carretero-Anibarro
    Xavier Mundet
    Juan J. Gorgojo-Martínez
    Jesús Reviriego
    Advances in Therapy, 2021, 38 : 3857 - 3871
  • [10] Feasibility of improved glycemic control with insulin detemir and insulin glargine in combination with oral agents in insulin naive patients with type 2 diabetes
    Rosenstock, J
    Larsen, JJ
    Draeger, E
    Kristensen, HS
    Davies, M
    DIABETES, 2004, 53 : A145 - A145
12345